|
HS Code |
544644 |
| Generic Name | Doxepin Hydrochloride |
| Brand Names | Silenor, Sinequan, Adapin |
| Drug Class | Tricyclic antidepressant |
| Chemical Formula | C19H22N2O · HCl |
| Molecular Weight | 316.85 g/mol (base), 348.87 g/mol (hydrochloride) |
| Mechanism Of Action | Inhibits reuptake of norepinephrine and serotonin |
| Primary Uses | Depression, anxiety, insomnia |
| Dosage Forms | Capsules, tablets, oral solution, topical cream |
| Prescription Status | Prescription only |
| Side Effects | Drowsiness, dry mouth, constipation, blurred vision, weight gain |
| Contraindications | Glaucoma, urinary retention, hypersensitivity |
| Route Of Administration | Oral, topical |
| Half Life | 8–24 hours |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F) |
As an accredited Doxepin Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Doxepin Hydrochloride packaged in a sealed amber glass bottle, 100 grams, with tamper-evident cap and detailed labeling for laboratory use. |
| Shipping | Doxepin Hydrochloride is shipped in tightly sealed containers, protected from light and moisture. It is transported under controlled temperature conditions, typically room temperature, in accordance with regulatory and safety guidelines. All packages are clearly labeled with hazard information and handled by authorized personnel to ensure safe delivery and compliance with shipping regulations. |
| Storage | Doxepin Hydrochloride should be stored in a tightly closed container at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F). It must be kept away from moisture, heat, and direct light. The storage area should be dry, well-ventilated, and secure, ensuring the chemical is protected from incompatible substances and unauthorized access. |
|
Purity 99%: Doxepin Hydrochloride with purity 99% is used in pharmaceutical tablet formulation, where it ensures consistent therapeutic efficacy. Molecular Weight 315.87 g/mol: Doxepin Hydrochloride with a molecular weight of 315.87 g/mol is used in antidepressant medication manufacturing, where it allows precise dosage calculation. Melting Point 217°C: Doxepin Hydrochloride with a melting point of 217°C is used in controlled-release capsule production, where it enhances formulation stability during processing. Particle Size < 50 µm: Doxepin Hydrochloride with particle size less than 50 µm is used in oral suspension preparations, where it promotes uniform dispersion and absorption. Solubility in Water 50 mg/mL: Doxepin Hydrochloride with solubility in water of 50 mg/mL is used in intravenous injection solutions, where it enables rapid onset of action. Stability Temperature up to 40°C: Doxepin Hydrochloride with stability temperature up to 40°C is used in global pharmaceutical distribution, where it maintains potency under varied storage conditions. Residual Solvent < 0.1%: Doxepin Hydrochloride with residual solvent less than 0.1% is used in GMP-compliant drug manufacturing, where it meets regulatory safety standards. pH 4.5–5.5 (1% solution): Doxepin Hydrochloride with pH range 4.5–5.5 in 1% solution is used in liquid oral drug formulations, where it ensures chemical stability and patient compatibility. |
Competitive Doxepin Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Doxepin Hydrochloride has been around for decades, building a steady reputation among healthcare professionals for its lasting value in mental health and sleep care. It stands as a tricyclic compound, introduced at a time when psychiatric support meant having reliable medications at hand. Most people hear about doxepin in the clinic when searching for help with conditions like depression, anxiety, or certain chronic sleep disturbances. Sitting on that pharmacy shelf next to newer antidepressants and sleep aids, doxepin’s story reflects both medical tradition and a touch of adaptability as patient needs evolve.
At its core, doxepin brings relief by balancing brain chemistry. It isn’t a one-trick pony: blocking the re-uptake of neurotransmitters like serotonin and norepinephrine gives it a dual action. These chemicals play a key role in mood and emotions, and by keeping their levels higher in the brain, doxepin has shown a reliable effect in easing depression and anxiety. This multi-pronged action also contributes to its usefulness for insomnia, especially the kind linked to anxious thoughts at night. Just a low dose of doxepin has helped people fall asleep faster and stay asleep longer, which can make a real difference after someone’s spent years struggling to get a full night’s rest.
Doctors don’t have a one-size-fits-all approach with doxepin. Sometimes it’s prescribed as a tablet, other times as a capsule or even a liquid, allowing for more precise management of different conditions and age groups. The original lineup includes options like 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg tablets or capsules—each one useful for different symptom severity. Lower strengths, such as the 3 mg and 6 mg tablets, entered the market more recently and focus on sleep issues, particularly in older adults who may be sensitive to medication side effects.
Those who’ve sat across from their doctor, worried about both mood swings and sleeping problems, can understand the value of a medicine that covers both. I’ve heard clinicians mention how a flexible dosing schedule helps them customize care, letting patients begin at low doses to sidestep unwanted drowsiness during the day. Doxepin even appears in topical creams for itchy skin caused by eczema or other chronic problems, broadening its reach far beyond mental health.
With a flood of newer antidepressants and sleep drugs, doxepin sometimes slips into the background. Doctor offices now stock many options labeled as selective serotonin reuptake inhibitors (SSRIs) or non-benzodiazepine sleep aids. These products often get pushed as “first choice” for new patients, citing milder side effects and less risk of dangerous interactions. Still, doxepin keeps its spot for certain people. Some SSRIs bring on jitteriness or prove too stimulating for anxious personalities, and others barely nudge stubborn insomnia. In those cases, doxepin’s old-school profile provides an alternative—with decades of data, not just hopeful marketing.
Personal experience in family medicine has shown that patients who respond poorly to newer antidepressants sometimes swing back to tricyclics like doxepin. Although less fashionable, it works where some trendy options do not. On the sleep side, newer agents such as zolpidem can prompt odd behaviors like overnight wandering or memory issues, while low-dose doxepin works more predictably by gently calming the brain’s histamine system. Over time, both patients and providers appreciate knowing that an established medicine can still compete on merits, not just popularity.
Relying on something that has stuck around for over 50 years may sound uninspiring, but doctors and patients hold to doxepin because of its consistent track record. People living with depression need more than just fleeting relief, and medications with more history behind them often deliver stable results. Compared to new releases that might promise the world, doxepin’s reputation grew out of clinical realities. Reports over the decades document its role in quelling strong depressive episodes—especially those marked by double trouble: anxiety and insomnia.
For seniors or those sensitive to drug side effects, the availability of ultra-low doses bolsters safety. It meets an unmet need, since many older patients either can’t take or won’t tolerate next-generation sleep pills. My experience in primary care revealed that patients with tough cases of chronic itching or sleep cycling found new hope in doxepin, whereas other medications had failed them completely.
Any medicine with power to help will also bring risks. Doxepin, as a tricyclic, can affect heart rhythm, trigger dry mouth, cause weight gain, or leave an unpleasant feeling of grogginess if taken at a higher dose. For those worried about falls or confusion, especially among elderly patients, careful monitoring matters. Yet new drugs aren’t always easier on the body—reports show “modern” sleep aids or antidepressants have their own set of challenges, including dependency or rare but serious side effects.
Not everyone responds the same way to doxepin. It’s smarter to approach treatment with an open mind rather than expecting a miracle fix. Good physicians start low, go slow, and focus on shared decision-making. Like any mature product, doxepin doesn’t carry flashy claims, but relies on plain evidence and the lived experience of those who stick with it.
One thing that stands out for doxepin is its accessibility. Most insurance plans cover it, and pharmacies keep it stocked in several forms, so getting a prescription filled doesn’t turn into a waiting game. Cost matters, especially for patients managing multiple prescriptions on a tight budget. Doxepin, out of patent for years, costs much less than many newly released drugs. In practice, that means treatment continues even if insurance coverage shifts or patients switch care providers. My patients have often expressed relief knowing their medication won’t break the bank, reducing both anxiety and administrative headaches.
You won’t see doxepin splashed across glossy ads or hyped in TV commercials, but its staying power comes down to versatility and experience. While newer antidepressants focus narrow, single-pathway actions, doxepin covers a wider range of symptoms, including physical pain sometimes linked with depression. The addition of topical and low-dose options means healthcare providers can tackle not only psychiatric problems but also stubborn cases of itching that steal sleep and peace of mind.
In sleep medicine, low-dose doxepin delivers good results for people who rarely felt rested, tackling nighttime wakefulness without the kind of “hangover” associated with other drugs. In real-world use, its effect on sleep gradually improves the next day’s mood and function, supporting mental health in small, tangible ways each morning.
Many new medicines flood the market each year, each one recommending itself as the solution to common problems—yet many patients continue to cycle through formulas, chasing the right balance. Placing doxepin among the options broadens the pathway to lasting wellness. Providers can revisit this time-tested medication for those cycling through more modern agents who miss out on symptom control. Patients can bring up doxepin in their consultations, especially if newer drugs left them grappling with side effects, sleeplessness, or persistent itching.
Researchers have also started revisiting older drugs, including doxepin, in light of new evidence on brain chemistry and personalized care. Those compiling treatment plans in psychiatry, sleep medicine, and dermatology now often account for individual genetics and medication sensitivity. Flexibility in dosing and delivery format—whether pills, liquids, or creams—ensures that care plans stay realistic. Those searching for “something else” after modern treatments fall short should not overlook the value tucked away in doxepin’s unimposing label.
Healthcare today rarely means single-drug therapy. Doxepin’s profile means careful teamwork among prescribing doctors, especially for those on multiple medications or with pre-existing health conditions. Interactions with monoamine oxidase inhibitors, alcohol, or certain antibiotics can pose dangers if not managed well, and the tricyclic class does require periodic check-ins for vital signs and lab work. Still, experienced clinicians recognize these points and supervise therapy—not unlike managing any complex drug regimen.
Floors of hospitals and primary care clinics run into patients who either can’t afford new therapies or find their side effects intolerable. In these cases, doxepin bridges the gap. It’s a solid back-up for sleep complaints that aren’t rooted in simple stress or daily routine, and for mood complaints where newer medications haven’t restored peace. Outcomes improve when providers recognize both the scientific heritage and the practical real-world strengths this long-standing medication offers.
Research into antidepressants and sleep drugs moves fast, but not every new compound proves better just because it’s new. Decades of published clinical trials, patient stories, and after-market safety monitoring give doxepin a strong foundation for trust. Study reviews in major medical journals continue to reference its reliable track record for melancholic and anxious depression. In sleep studies, those struggling with sleep maintenance—especially older adults—found doxepin both effective and tolerable.
Listening to patients in a busy clinic gives context beyond the numbers. One elderly woman, after years of restless sleep, finally secured uninterrupted nights through a low-dose doxepin prescription, improving her focus and mood the next day. In another case, a middle-aged man wrestling with chronic itching regained quality of life through the topical formulation, avoiding the need for heavy-duty steroids. These aren’t rare stories; versions echo in clinics everywhere.
Today’s patients demand more than the latest buzz in pharmaceuticals. They want practical solutions based on longevity and reliability. Doxepin’s blend of broad indications and flexible dosing options positions it as a medicine that adapts to individual needs rather than dictating a narrow course.
Current research groups keep circling back to tricyclics for tough-to-treat depression, complex sleep complaints, or persistent skin conditions. While precision medicine and genetic profiling move forward, the backbone remains proven drugs like doxepin, ready to support both primary and specialty care. The challenge comes not from lack of evidence or options but from remembering that newer isn’t always better. An honest review of a patient’s overall health—mental, physical, and financial—keeps doxepin in active conversation about medication planning.
Pharmacists and doctors who value patient trust often land on doxepin for its balance of practicality and proven benefit. The conversation starts by reviewing individual goals: more restful sleep, relief from depression, or management of chronic itching. Carefully tracking response, watching for side effects, and adjusting doses when needed ensures safety and satisfaction. Family members caring for elderly relatives often seek consistency, and doxepin’s cost-effective profile stretches healthcare dollars without sacrificing quality.
New practitioners joining the field benefit from learning the history and present uses of medicines like doxepin. Unlike trend-driven products, its place in care rests on real-world results, community wisdom, and the kind of shared stories found in waiting rooms and homes across the globe. Growing evidence now supports its selective use even as more expensive or heavily marketed products crowd the clinical scene.
Years in healthcare have shown that challenges rarely arrive in neat packages. Depression, sleep trouble, itching—these often overlap, complicating quick fixes. Doxepin meets many of these needs with clinical efficiency. Staff I’ve worked alongside frequently point to low rates of patient drop-out, thanks to doxepin’s affordability and familiar side effect profile. Patients who value predictability in their lives often do best, especially when given time to adjust to the medication and receive honest guidance.
Professional guidelines recommend keeping personal preference in mind, not just textbook indications. For anyone who has hit a wall with modern, single-target agents, a return to doxepin may bring welcome relief. Even in an age driven by technology and new science, this classic medicine earns its place, one patient at a time.
Doctors, pharmacists, and patients can strengthen their working relationships by talking openly about treatment choices. Doxepin may not dazzle with new technology, but in the hands of skilled professionals, it covers real-world problems faced by real people. Ongoing patient education, flexible dosing, and transparent communication about side effects all support better outcomes. Regular review of both current research and lived experience can ensure that doxepin continues providing real relief for those who need it most.
Experience in clinics both busy and quiet has reinforced the point: medicines don’t need to grab headlines to make a difference. Doxepin Hydrochloride stands on its merits, offering practical support for patients spinning through cycles of mood and sleep disturbances, or wrestling with chronic itching. Doctors return to it time after time because the results hold up and the risk-benefit profile remains favorable for those who need flexible, reliable care. While trends shift and new drugs promise improved outcomes, the reality for many patients begins with a conversation about what has stood the test of time—and doxepin fits that bill.
For those searching for a time-tested answer that respects both medical science and patient experience, doxepin stands ready—expected, prepared, and proven.